Sean McConachie Pharm.D.

Sean McConachie Pharm.D.

Title

Assistant Professor (Clinical)

Department

Pharmacy Practice

Phone

313-577-4454

Email

sean.mcconachie@wayne.edu

Sean McConachie Pharm.D.

Degrees and Certifications

Degrees
  • 2015 - Pharm.D., Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University
  • 2011 - B.S. in Diagnostic Molecular Science, Michigan State University

Certification

  • 2017 - Board Certified Pharmacotherapy Specialist

Positions and Employment

  •  2017-present - Assistance Clinical Professor, Wayne State University

Awards and Honors

  • 2018 - American Society of Health System Pharmacist’s Best Practice Award
  • 2018 - Michigan Society of Health System Pharmacist’s President’s Award
  • 2018 - Southeastern Michigan Society of Heath System Pharmacist’s Innovative Practice Award

Professional Memberships

  • 2017-present - Michigan Pharmacists Association
  • 2016-present - Southeastern Michigan Society of Health-System Pharmacists
  • 2013-present - American Society of Health-System Pharmacists
  • 2012-present - American College of Clinical Pharmacy

Areas of Expertise

  • Transitions of care
  • Internal medicine

Primary Research Interest

Research in Progress
  • McConachie SM, Giuliano C, Mohammad I, Kale-Pradhan, P. Adverse Drug Reactions in Drug Information Databases: Does Presentation Affect Interpretation? Wayne State University, Detroit, MI.

Non-Funded Research in Last Five Years

  • McConachie SM, Hanni C, Raub J, Wilhelm SM. National Assessment of Renal Estimating Practices for Drug Dosing. Wayne State University, Detroit, MI.
  • McConachie SM, Raub J, Yost R, Monday L, Agrawal S, Tannous P. A Multidisciplinary Approach to Reduce Internal Medicine Readmissions Using a Readmission Prediction Index. Wayne State University, Harper University Hospital, Detroit, MI.
  • McConachie, SM, Yost, R, Raub, J. Prospective Validation of a 30-Day Readmission Prediction Index. Wayne State University, Detroit Medical Center. Detroit, MI.
  • McConachie, SM, Johnson, J, Wahby KA, Petrovitch, E. Evaluation and Identification of Warfarin-Related Reversal Agents and Outcomes. Wayne State University, Harper University Hospital. Detroit, MI.
  • McConachie SM, Mills J, Bressler A. The Effect of Automatic Stop-Dates on Antimicrobial Outcomes. DeKalb Medical Center. Decatur, GA.

Recent Publications

  •  Wilhelm, SM, McConachie SM. Mcgraw-Hill Education Naplex Review, Third Edition. Chapter: Inflammatory Bowel Diseases. 2017. (In Press)
  • McConachie SM, Raub JN, Trupiano, D, Yost R. Development of an iterative validation process for a 30-day hospital readmission prediction index. Am J Health-Syst Pharm. 2019;76(7):444-452.
  • McConachie SM, Hanni CM, Raub JN, Wilhelm SM. National Assessment of Renal Estimation for Drug Dosing among Pharmacists. Journal of the American College of Clinical Pharmacy. 2018 (ahead of print)
  • Hanni CM, Wilhelm SM, Korkis B, Petrovitch EA, Tsilimingras KV, McConachie SM. Therapeutic Enoxaparin in the Morbidly Obese Patient: A Case Report and Review of the Literature. Hospital Pharmacy. 2018 (ahead of print).
  • McConachie S, Wahby KA, Almadrahi Z, Wilhelm SM. Early Experiences with PEGylated Carboxyhemoglobin Bovine in Anemic Jehovah’s Witnesses: A Case Series and Review of the Literature. J Pharm Pract. 2018 (ahead of print).
  • McConachie SM, Almadrahi Z, Wahby KA, Wilhelm SM. Pharmacotherapy in Acutely Anemic Jehovah’s Witnesses: An Evidence-Based Review. Ann Pharmacother. 2018; 52(9): 910-919.
  • McConachie SM, Wilhelm SM, Bhargava A, Kale-Pradhan PB. Biologic-Induced Infections in Inflammatory Bowel Disease: The TNF-α Antagonists. Ann Pharmacother. 2018; 52(6): 571-579.
  • McConachie S, Wilhelm SM and Kale-Pradhan PB. Biosimilars in Inflammatory Bowel Disease – Accumulating Clinical Evidence. Expert Rev Clin Pharmacol. 2017 Apr; 10(4): 391-400. Epub 1/18.
  • McConachie SM, Wilhelm SM and Kale-Pradhan PB. New Direct-Acting Antivirals in Hepatitis C Therapy: A Review of Sofosbuvir, Ledipasvir, Daclatasvir, Simeprevir, Paritaprevir, Ombitasvir and Dasabuvir. Expert Rev Clin Pharmacol. 2016; 9(2):287-302. Epub 1/16.
  • McConachie, SM, Franckowiak, T, Yost, R, Raub, J, MacDonald J, Risko, K, Garwood C, Petrovitch E. Derivation and implementation of a 30-day hospital readmission risk index. Pharmacotherapy (online). 2017; 37(6).